Glucose pump test: a new method for blood flow measurements

Area of Science:

• Nephrology
• Vascular Access Monitoring
• Hemodynamics

Background:

• Accurate, rapid, and economical monitoring of vascular access blood flow (Q(a)) is crucial for frequent, easy measurements.
• The Glucose Pump Test (GPT) utilizes a constant glucose infusion as a dilutional indicator for Q(a) assessment.

Purpose of the Study:

• To introduce and validate the Glucose Pump Test (GPT) as a novel method for monitoring vascular access blood flow (Q(a)).
• To compare the accuracy and reliability of GPT-Q(a) against established methods like Doppler ultrasound and the Transonic HD01 system.

Main Methods:

• GPT involves a constant arterial glucose infusion and two venous blood withdrawals to calculate Q(a) using a specific formula.
• Method validation included in vitro testing and in vivo comparisons in 23 chronic hemodialysis patients against Doppler ultrasound and Transonic HD01.

Main Results:

• GPT-Q(a) demonstrated high correlation in vitro (r=0.94) and good correlation with Transonic HD01 in vivo (r=0.95).
• GPT showed agreement with Doppler ultrasound (mean flow 927.5 vs 927.1 ml/min, P=NS).
• Transonic HD01 yielded significantly lower mean flow values (690 ml/min) compared to GPT and Doppler, with significant differences observed in regression analysis.

Conclusions:

• GPT is a simple, non-intrusive bedside procedure performed before dialysis, not interfering with treatment.
• GPT offers an advantageous, economical, and potentially useful method for routine vascular access flow monitoring in dialysis units.